| |
|
Thursday 14th January 2010 |
|
|
| 0930 |
Paul Taylor |
Liquid Chromatography - Tandem Mass Spectrometry in the Clinical Laboratory: Now and Into the Future |
|
|
| 1045 |
Alan Rockwood |
Developing an LC-MS/MS Method for Hepcidin Quantitative Analysis |
Alan Wu |
Phenotyping vs Genotyping for Pharmacogenomics: Expanded roles for LC/MS |
| |
Neil Dalton |
MSMS Measurement of New Biomarkers of Liver & Kidney Functions and Brain Damage |
Nancy Tsui |
Detection of Fetal Chromasomal Aneuploidies by MS Analysis of Cell-Free Fetal Nucleic Acids in Maternal Plasma |
| |
Malcolm Whiting |
Measurement of Biogenic Amines and Their Metabolites by LC-MS/MS |
Terence Poon |
Potentials and Pitfalls in Applying ProteinChip SELDI Technology to Biomarker Discovery |
| |
Ravinder Singh |
Measurement of Renin Activity Using Tandem Mass Spectrometry |
|
|
| 1245 |
Matthew Grigg |
Applied Biosystems Workshop |
Jimmy Chan |
Agilent Technologies Workshop |
| |
Ravinder Singh |
Impact of Tandem Mass Spectrometry in Clinical Diagnostics |
|
|
| |
Frank Kühlwein |
Chromsystems Workshop |
|
|
| 1430 |
Neil Dalton |
Simultaneous High Throughput MSMS Measurement of Dried Blood Spot Proteins, Enzyme Activities and Metabolites for Diagnosis of IEM and Haemoglobinopathies |
|
|
| 1545 |
Brett McWhinney |
The Analysis of Glucocorticoid Steroids in Plasma, Urine and Saliva by UPLC/MS/MS |
Michael Chan |
ICP-MS: A Tool to Uncover Myths |
| |
CS Ho |
Female Androgens Profile by MS for PCOS Patients |
John Joseph |
Assessment of Pre-Fortification Iodine Status by ICPMS in the West Australian Population |
| |
Paul Taylor |
A Semi-Automated LC-MS Method for Aldosterone Measurement |
John Earl |
LC-MS, HPLC and Immunoassay Performance in External QAP for Biogenic Amines |
| |
Conchita Boyder |
Serum Testosterone in Females by Liquid Chromatography Tandem Mass Spectrometry |
Ronda Greaves |
Quality Assurance Aspects of Vitamin Analysis |
| |
|
|
|
|
| |
|
Friday 15 January 2010 |
|
|
| 0930 |
Alan Wu |
LC Tandem MS and TOF MS: A new paradigm for emergency department drug testing |
|
|
| 1015 |
Paul Taylor |
Update on TDM of Immunosuppressants Using LCMS Method |
Alan Rockwood |
Use of Derivatisation for LC-MS/MS Analysis in the Clinical Laboratory |
| |
Tony Mak |
Aconite Poisonings in Hong Kong in the Past 5 Years: The usual and the unusual |
Neil Dalton |
Development of a Reference MSMS Method for Plasma Creatinine |
| |
SW Ng |
Illicit Weight-Reducing Agents: The challenges faced by the Toxicology Reference Laboratory in Hong Kong |
Ravinder Singh |
Quantification of Human 1-84 PTH in Serum and Plasma by Immunocapture in-situ-digestion LC-MS/MS |
| |
Michael Lee |
Performance of an UPLC-TOF MS Method for Comprehensive Urine Drug Screening in 4 Routine Clinical Chemistry Laboratories Sharing Common Libraries |
Mike Morris |
Future Paths for Mass Spectrometry in Routine Clinical Chemistry |
| 1215 |
Mike Morris |
Waters Workshop |
|
|
| 1400 |
Alan Rockwood |
Challenges in Operating a High Throughput Routine Clinical LC-MS/MS |
|
|
| 1515 |
James Pitt |
Improving the Detection of Inborn Errors of Metabolism Using LC/MSMS |
Ronda Greaves |
Vitamin A - The First Vitamin |
| |
Eric Law |
Diagnosis of Fatty Acid Oxidation Disorders by Mass Spectrometry |
Brett McWhinney |
LC/MS/MS Measurement of Vitamin D3 and D2: Present and the Future |
| |
John Earl |
A Window on the Brain: Analysis of Neurotransmitters, Vitamins and Cofactors |
Peter George |
Coenzyme Q |
| 1645 |
Sam Vasikaran, APFCB Travelling Lecturer |
The Endocrine Diagnostic Service, from Immunoassay to Chromatography and Mass Spectrometry: A Clinical Perspective |
|
|
